Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.845
-0.140 (-4.69%)
At close: Apr 28, 2026, 4:00 PM EDT
2.850
+0.005 (0.18%)
After-hours: Apr 28, 2026, 7:46 PM EDT
Processa Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 8 | 7 | 3 | 8 | 18 | 77 | |
| Market Cap Growth | 482.14% | 126.00% | -64.97% | -53.14% | -77.16% | 10.51% | |
| Enterprise Value | 2 | 0 | 0 | 2 | 9 | 58 | |
| Last Close Price | 2.85 | 2.88 | 22.09 | 167.30 | 550.00 | 2450.00 | |
| PB Ratio | 1.31 | 1.17 | 1.70 | 1.65 | 2.35 | 3.02 | |
| P/TBV Ratio | 1.36 | 1.17 | 1.70 | 1.65 | 2.35 | 4.42 | |
| Debt / Equity Ratio | - | - | 0.04 | 0.03 | 0.03 | 0.00 | |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -0.66 | -0.91 | -0.84 | -0.64 | |
| Net Debt / EBITDA Ratio | 0.40 | 0.40 | 0.09 | 0.40 | 0.32 | 1.52 | |
| Net Debt / FCF Ratio | 0.49 | 0.49 | 0.10 | 0.56 | 0.65 | 1.88 | |
| Quick Ratio | 2.48 | 2.48 | 0.78 | 6.44 | 6.51 | 17.06 | |
| Current Ratio | 2.54 | 2.54 | 1.23 | 7.71 | 8.40 | 18.87 | |
| Return on Equity (ROE) | -372.97% | -372.97% | -354.51% | -178.52% | -166.43% | -47.20% | |
| Return on Assets (ROA) | -158.34% | -158.34% | -167.08% | -99.41% | -72.17% | -27.98% | |
| Return on Capital Employed (ROCE) | -250.80% | -250.80% | -710.30% | -226.60% | -265.80% | -45.40% | |
| Earnings Yield | -179.23% | -207.86% | -410.42% | -134.94% | -155.91% | -14.84% | |
| FCF Yield | -150.44% | -174.47% | -389.58% | -97.87% | -54.61% | -11.32% | |
| Buyback Yield / Dilution | -969.33% | -969.33% | -133.38% | -62.83% | -5.16% | -104.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.